- Home
- EPOW vs FEMY Comparison
EPOW vs FEMY Comparison
Compare EPOW & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- FEMY
- Stock Information
- Founded
- EPOW 2014
- FEMY 2004
- Country
- EPOW China
- FEMY United States
- Employees
- EPOW N/A
- FEMY N/A
- Industry
- EPOW Business Services
- FEMY Medical/Dental Instruments
- Sector
- EPOW Consumer Discretionary
- FEMY Health Care
- Exchange
- EPOW Nasdaq
- FEMY Nasdaq
- Market Cap
- EPOW 24.5M
- FEMY 31.9M
- IPO Year
- EPOW 2021
- FEMY 2021
- Fundamental
- Price
- EPOW $0.99
- FEMY $0.96
- Analyst Decision
- EPOW
- FEMY Strong Buy
- Analyst Count
- EPOW 0
- FEMY 3
- Target Price
- EPOW N/A
- FEMY $8.67
- AVG Volume (30 Days)
- EPOW 12.0K
- FEMY 362.3K
- Earning Date
- EPOW 07-15-2025
- FEMY 08-07-2025
- Dividend Yield
- EPOW N/A
- FEMY N/A
- EPS Growth
- EPOW N/A
- FEMY N/A
- EPS
- EPOW N/A
- FEMY N/A
- Revenue
- EPOW $64,997,741.00
- FEMY $1,699,232.00
- Revenue This Year
- EPOW N/A
- FEMY $231.84
- Revenue Next Year
- EPOW N/A
- FEMY $245.28
- P/E Ratio
- EPOW N/A
- FEMY N/A
- Revenue Growth
- EPOW 44.28
- FEMY 61.97
- 52 Week Low
- EPOW $0.55
- FEMY $0.69
- 52 Week High
- EPOW $1.36
- FEMY $1.80
- Technical
- Relative Strength Index (RSI)
- EPOW 57.27
- FEMY 48.09
- Support Level
- EPOW $0.88
- FEMY $0.91
- Resistance Level
- EPOW $0.96
- FEMY $0.95
- Average True Range (ATR)
- EPOW 0.04
- FEMY 0.06
- MACD
- EPOW 0.01
- FEMY 0.01
- Stochastic Oscillator
- EPOW 87.50
- FEMY 31.16
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.